Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. Stock DD Board Message Board

Ansell Cap Corp (ANCCF) 0.1897 $ANCCF BriaCell

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 273322
Posted On: 09/14/2016 3:03:40 AM
Avatar
Posted By: Stock_Tracker
Ansell Cap Corp (ANCCF) 0.1897 $ANCCF

BriaCell Launches Development of Companion Diagnostic Product, BriaDx(TM)
Marketwired - Mon Sep 14, 8:30AM CDT
BriaCell Therapeutics Corp (OTCQB: ANCCF) (TSX VENTURE: BCT) ("BriaCell", the "Company", or "BCT" is pleased to announce the initiation of its key research and development program pertaining to BriaCell's novel companion diagnostic product, which is to be called "BriaDx(TM)".
BCT.VN: 0.210 (unch)

Immuno-Oncology Biotech BriaCell Attracts Top Scientist to Head R&D
Marketwired - Wed Jul 15, 8:03AM CDT
BriaCell Therapeutics Corp (OTCQB: ANCCF) (TSX VENTURE: BCT) ("BriaCell", the "Company", or "BCT" announced today that Markus Lacher, Ph.D. has been appointed as Senior Director, Research and Development. Dr. Lacher will immediately assume all responsibility for the development and execution of all research and process development plans for the Company's lead product, BriaVax(TM), a cell-based cancer immunotherapy. In addition, Dr. Lacher will also assume responsibility for analyzing samples obtained from patients treated in the Company's upcoming Phase I/II clinical trial. Having served in a senior scientific role in the development programs of numerous cell therapy and diagnostic products, Dr. Lacher brings to BriaCell extensive experience within the biotechnology industry.
BCT.VN: 0.210 (unch)

BriaCell Therapeutics Begins Trading on the OTCQB (ANCCF) and Presents at a New York Biotech Investor Conference
Marketwired - Wed Jun 24, 8:30AM CDT
BriaCell Therapeutics Corp (TSX VENTURE: BCT) (OTCQB: ANCCF) ("BriaCell", the "Company", or "BCT", a clinical stage cancer immunotherapy company, has been approved to begin trading today on the OTCQB® Marketplace in the United States under the symbol "ANCCF". The Company will continue to trade on the Toronto Stock Exchange Venture under the symbol "BCT".
BCT.VN: 0.210 (unch)

BriaCell Therapeutics Announces Closing of Go-Public Onto Toronto Stock Exchange Venture, Closing of Concurrent Financing With Agents Sunel Securities and M Partners, Closing of Hospital Partnership and Royalty Relinquishment Corporate Update
GlobeNewswire - Wed Dec 03, 11:26AM CST
BriaCell Therapeutics Corp (TSX-V:BCT) ("BriaCell", the "Company", or "BCT" is pleased to announce that it has, effective December 1, 2014, completed its Go-Public Event onto the Toronto Stock Exchange Venture (the "Go-Public" and concurrent financing (the "Financing" (together referred to as the "Transaction" with Ansell Capital Corp ("Ansell". The Company's shares are now trading under the symbol BCT. The terms of the Go-Public Event, which was structured as a Reverse Takeover ("RTO" under the rules and policies of the TSX Venture Exchange (the "TSX-V", were previously announced by the Company in a release dated April 17, 2014. The Transaction was approved by 100.00% of shareholders. At a deemed value of $0.18 the Company's market value is approximately $15 million.
BCT.VN: 0.210 (unch)

IIROC Trading Resumption - BCT
CNW Group - Tue Dec 02, 3:12PM CST
Trading resumes in:



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us